Business Unit:
Corporate Finance
Industry:
HC - Healthcare
Overview
Houlihan Lokey, Inc. (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and financial and valuation advisory. Houlihan Lokey serves corporations, institutions, and governments worldwide with offices in the Americas, Europe, the Middle East, and the AsiaPacific region. Independent advice and intellectual rigor are hallmarks of the firm’s commitment to client success across its advisory services. The firm is the No. 1 investment bank for all global M&A transactions, the No. 1 M&A advisor for the past nine consecutive years in the U.S., the No. 1 global restructuring advisor for the past ten consecutive years, and the No. 1 global M&A fairness opinion advisor over the past 25 years, all based on number of transactions and according to data provided by LSEG (formerly Refinitiv).
Corporate Finance
The Houlihan Lokey Corporate Finance business has extensive expertise in mergers, acquisitions, divestitures, activist shareholder and takeover defense, and other related advisory services for a broad range of clients. In addition, we have the proven ability to engineer and execute financing solutions that are essential for growth and success and offer access to financing in the public and alternative capital markets through the issuance of debt, equity, or hybrid securities.
In EMEA, we work with a wide spectrum of companies, from mid-market privately owned enterprises to large multinational organizations. With a growing EMEA platform with nearly 400 Corporate Finance bankers in offices across the UK, Germany, Switzerland, Italy, France, Sweden, Spain, Israel, the Netherlands, and Dubai, we have the breadth and targeted expertise to provide exceptional client service.
Healthcare
Houlihan Lokey’s Healthcare group is one of the most active and trusted partners in healthcare, providing M&A advisory and capital-raising services to middle market leaders across medical technology, healthcare IT, healthcare services, managed care and life sciences. With over 70 investment bankers globally and 20 based in Europe, Houlihan Lokey’s Healthcare Group is among the largest dedicated and fastest growing healthcare investment banking groups.
Scope
As a Graduate Financial Analyst, you will work on corporate finance engagements for companies within our Healthcare M&A advisory team. The group’s engagements principally include sell-side and buy-side M&A transactions. As a dedicated member of our transaction team, you will be responsible for supporting these assignments. You will work with a talented, dedicated staff of professionals who will give you broad exposure to the many different issues and concerns affecting companies and investors today.
You will research and analyse financial statements, general economic conditions, industry-specific developments, acquisitions and divestitures, and investment attributes of publicly traded and private companies. You will also gain in-depth knowledge of capital raisings and financing structures.
Houlihan Lokey provides a collegial, entrepreneurial work environment. We reward our Financial Analysts with substantial responsibilities, interaction with senior-level professionals, and live engagements.
Requirements/Qualifications

The ideal candidate will have:

• A strong academic track record from a highly regarded university –– completing your final university assessments in Spring or Summer 2025
• Minimum 3 months internship experience in M&A or another similar role, with experience/knowledge in Healthcare favourably regarded
• Strong quantitative and analytical skills with a focus on accuracy and attention to detail
• An understanding of valuation theory, methodologies and applications
• Strong quantitative, financial and analytical skills
• Proficient skill in Excel and PowerPoint
• Strong interpersonal skills
• Most importantly, we seek to attract dedicated, team-oriented candidates with a deep desire to win, a strong work ethic, and a willingness to work hard to achieve the highest standards of performance

Please note that our Graduate Financial Analyst Training commences on 14 July 2025, so you must be available to start full-time work by this date to be eligible for this position.
We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability, gender identity, sexual orientation, protected veteran status, or any other characteristic protected by law

Please refer the Job description for details